nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR2A—Gilles de la Tourette syndrome	0.731	1	CbGaD
Methysergide—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00901	0.12	CbGeAlD
Methysergide—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00562	0.0749	CbGeAlD
Methysergide—HTR1F—nervous system—Gilles de la Tourette syndrome	0.00361	0.0481	CbGeAlD
Methysergide—HTR1F—central nervous system—Gilles de la Tourette syndrome	0.00347	0.0463	CbGeAlD
Methysergide—HTR1E—nervous system—Gilles de la Tourette syndrome	0.00312	0.0417	CbGeAlD
Methysergide—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.00301	0.0401	CbGeAlD
Methysergide—HTR1F—brain—Gilles de la Tourette syndrome	0.00276	0.0368	CbGeAlD
Methysergide—HTR6—nervous system—Gilles de la Tourette syndrome	0.00245	0.0327	CbGeAlD
Methysergide—HTR1E—brain—Gilles de la Tourette syndrome	0.00239	0.0318	CbGeAlD
Methysergide—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00236	0.0315	CbGeAlD
Methysergide—HTR6—brain—Gilles de la Tourette syndrome	0.00187	0.025	CbGeAlD
Methysergide—HTR1B—midbrain—Gilles de la Tourette syndrome	0.0018	0.024	CbGeAlD
Methysergide—HTR1D—midbrain—Gilles de la Tourette syndrome	0.00174	0.0232	CbGeAlD
Methysergide—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00172	0.023	CbGeAlD
Methysergide—SIGMAR1—midbrain—Gilles de la Tourette syndrome	0.00162	0.0216	CbGeAlD
Methysergide—HTR1B—nervous system—Gilles de la Tourette syndrome	0.00148	0.0197	CbGeAlD
Methysergide—HTR1A—midbrain—Gilles de la Tourette syndrome	0.00145	0.0193	CbGeAlD
Methysergide—Lisuride—DRD4—Gilles de la Tourette syndrome	0.00145	0.136	CrCbGaD
Methysergide—HTR1D—nervous system—Gilles de la Tourette syndrome	0.00143	0.0191	CbGeAlD
Methysergide—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.00142	0.019	CbGeAlD
Methysergide—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00142	0.0189	CbGeAlD
Methysergide—HTR7—midbrain—Gilles de la Tourette syndrome	0.00139	0.0185	CbGeAlD
Methysergide—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.00138	0.0184	CbGeAlD
Methysergide—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.00136	0.0182	CbGeAlD
Methysergide—Bromocriptine—DRD4—Gilles de la Tourette syndrome	0.00134	0.126	CrCbGaD
Methysergide—HTR2B—nervous system—Gilles de la Tourette syndrome	0.00133	0.0177	CbGeAlD
Methysergide—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.00128	0.0171	CbGeAlD
Methysergide—Lisuride—DRD3—Gilles de la Tourette syndrome	0.00125	0.118	CrCbGaD
Methysergide—HTR1A—nervous system—Gilles de la Tourette syndrome	0.00119	0.0159	CbGeAlD
Methysergide—Bromocriptine—DRD3—Gilles de la Tourette syndrome	0.00115	0.109	CrCbGaD
Methysergide—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.00115	0.0153	CbGeAlD
Methysergide—HTR7—nervous system—Gilles de la Tourette syndrome	0.00114	0.0152	CbGeAlD
Methysergide—HTR1B—brain—Gilles de la Tourette syndrome	0.00113	0.0151	CbGeAlD
Methysergide—HTR7—central nervous system—Gilles de la Tourette syndrome	0.0011	0.0146	CbGeAlD
Methysergide—HTR1D—brain—Gilles de la Tourette syndrome	0.00109	0.0146	CbGeAlD
Methysergide—HTR2C—brain—Gilles de la Tourette syndrome	0.00108	0.0144	CbGeAlD
Methysergide—SIGMAR1—brain—Gilles de la Tourette syndrome	0.00102	0.0136	CbGeAlD
Methysergide—HTR2B—brain—Gilles de la Tourette syndrome	0.00102	0.0136	CbGeAlD
Methysergide—Methylergometrine—HTR2A—Gilles de la Tourette syndrome	0.000994	0.0938	CrCbGaD
Methysergide—HTR1A—brain—Gilles de la Tourette syndrome	0.000911	0.0122	CbGeAlD
Methysergide—HTR7—brain—Gilles de la Tourette syndrome	0.000871	0.0116	CbGeAlD
Methysergide—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000864	0.0115	CbGeAlD
Methysergide—Lisuride—DRD2—Gilles de la Tourette syndrome	0.000863	0.0814	CrCbGaD
Methysergide—Ergotamine—DRD2—Gilles de la Tourette syndrome	0.000829	0.0782	CrCbGaD
Methysergide—Bromocriptine—DRD2—Gilles de la Tourette syndrome	0.000799	0.0754	CrCbGaD
Methysergide—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000711	0.00948	CbGeAlD
Methysergide—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000684	0.00912	CbGeAlD
Methysergide—Lisuride—HTR2A—Gilles de la Tourette syndrome	0.000667	0.0629	CrCbGaD
Methysergide—Ergotamine—HTR2A—Gilles de la Tourette syndrome	0.00064	0.0605	CrCbGaD
Methysergide—Bromocriptine—HTR2A—Gilles de la Tourette syndrome	0.000618	0.0583	CrCbGaD
Methysergide—HTR2A—brain—Gilles de la Tourette syndrome	0.000543	0.00724	CbGeAlD
Methysergide—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000417	0.00227	CbGpPWpGaD
Methysergide—HTR1E—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000416	0.00226	CbGpPWpGaD
Methysergide—HTR1E—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000415	0.00226	CbGpPWpGaD
Methysergide—HTR1F—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000409	0.00223	CbGpPWpGaD
Methysergide—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000388	0.00211	CbGpPWpGaD
Methysergide—HTR1E—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000386	0.0021	CbGpPWpGaD
Methysergide—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000377	0.00205	CbGpPWpGaD
Methysergide—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000366	0.00199	CbGpPWpGaD
Methysergide—HTR7—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000356	0.00194	CbGpPWpGaD
Methysergide—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000355	0.00193	CbGpPWpGaD
Methysergide—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000351	0.00191	CbGpPWpGaD
Methysergide—HTR7—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000345	0.00188	CbGpPWpGaD
Methysergide—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000331	0.0018	CbGpPWpGaD
Methysergide—HTR7—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000322	0.00175	CbGpPWpGaD
Methysergide—HTR1D—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000312	0.0017	CbGpPWpGaD
Methysergide—HTR1B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000305	0.00166	CbGpPWpGaD
Methysergide—HTR1D—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000303	0.00165	CbGpPWpGaD
Methysergide—HTR1B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000297	0.00161	CbGpPWpGaD
Methysergide—HTR1F—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000295	0.00161	CbGpPWpGaD
Methysergide—HTR6—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000292	0.00159	CbGpPWpGaD
Methysergide—HTR7—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000291	0.00159	CbGpPWpGaD
Methysergide—HTR1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00029	0.00157	CbGpPWpGaD
Methysergide—HTR1F—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000287	0.00156	CbGpPWpGaD
Methysergide—HTR1F—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000287	0.00156	CbGpPWpGaD
Methysergide—HTR1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000283	0.00154	CbGpPWpGaD
Methysergide—HTR6—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000283	0.00154	CbGpPWpGaD
Methysergide—HTR7—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000283	0.00154	CbGpPWpGaD
Methysergide—HTR1D—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000282	0.00153	CbGpPWpGaD
Methysergide—HTR1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000281	0.00153	CbGpPWpGaD
Methysergide—HTR1E—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000279	0.00152	CbGpPWpGaD
Methysergide—HTR1B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000276	0.0015	CbGpPWpGaD
Methysergide—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000275	0.0015	CbGpPWpGaD
Methysergide—HTR1E—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000271	0.00147	CbGpPWpGaD
Methysergide—HTR1E—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000271	0.00147	CbGpPWpGaD
Methysergide—HTR1F—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000267	0.00145	CbGpPWpGaD
Methysergide—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000266	0.00145	CbGpPWpGaD
Methysergide—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000264	0.00144	CbGpPWpGaD
Methysergide—HTR7—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000264	0.00143	CbGpPWpGaD
Methysergide—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000262	0.00142	CbGpPWpGaD
Methysergide—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000259	0.00141	CbGpPWpGaD
Methysergide—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000256	0.00139	CbGpPWpGaD
Methysergide—HTR1E—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000252	0.00137	CbGpPWpGaD
Methysergide—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00025	0.00136	CbGpPWpGaD
Methysergide—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00025	0.00136	CbGpPWpGaD
Methysergide—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000248	0.00135	CbGpPWpGaD
Methysergide—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000246	0.00134	CbGpPWpGaD
Methysergide—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000243	0.00132	CbGpPWpGaD
Methysergide—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000243	0.00132	CbGpPWpGaD
Methysergide—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000242	0.00132	CbGpPWpGaD
Methysergide—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000241	0.00131	CbGpPWpGaD
Methysergide—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000241	0.00131	CbGpPWpGaD
Methysergide—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000236	0.00128	CbGpPWpGaD
Methysergide—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000233	0.00127	CbGpPWpGaD
Methysergide—HTR1E—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000232	0.00126	CbGpPWpGaD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000228	0.00124	CbGpPWpGaD
Methysergide—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000226	0.00123	CbGpPWpGaD
Methysergide—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000226	0.00123	CbGpPWpGaD
Methysergide—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000226	0.00123	CbGpPWpGaD
Methysergide—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000224	0.00122	CbGpPWpGaD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000221	0.0012	CbGpPWpGaD
Methysergide—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00022	0.00119	CbGpPWpGaD
Methysergide—HTR2B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000218	0.00119	CbGpPWpGaD
Methysergide—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000216	0.00117	CbGpPWpGaD
Methysergide—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000215	0.00117	CbGpPWpGaD
Methysergide—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00021	0.00114	CbGpPWpGaD
Methysergide—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00021	0.00114	CbGpPWpGaD
Methysergide—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000209	0.00113	CbGpPWpGaD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000206	0.00112	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000205	0.00111	CbGpPWpGaD
Methysergide—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000195	0.00106	CbGpPWpGaD
Methysergide—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000195	0.00106	CbGpPWpGaD
Methysergide—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000194	0.00106	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00019	0.00104	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00019	0.00103	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000189	0.00103	CbGpPWpGaD
Methysergide—HTR1F—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000187	0.00102	CbGpPWpGaD
Methysergide—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000187	0.00101	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000185	0.00101	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000185	0.00101	CbGpPWpGaD
Methysergide—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000185	0.00101	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000185	0.00101	CbGpPWpGaD
Methysergide—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000185	0.001	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000185	0.001	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000184	0.001	CbGpPWpGaD
Methysergide—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000183	0.000998	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000183	0.000997	CbGpPWpGaD
Methysergide—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000181	0.000985	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00018	0.000977	CbGpPWpGaD
Methysergide—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00018	0.000977	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00018	0.000977	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000179	0.000972	CbGpPWpGaD
Methysergide—HTR1E—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000176	0.00096	CbGpPWpGaD
Methysergide—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000176	0.000958	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000174	0.000945	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000172	0.000936	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000172	0.000935	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000171	0.000929	CbGpPWpGaD
Methysergide—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000169	0.000918	CbGpPWpGaD
Methysergide—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000169	0.000918	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000169	0.000917	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000167	0.00091	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000167	0.00091	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000167	0.000908	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000166	0.000906	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000162	0.000881	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00016	0.000869	CbGpPWpGaD
Methysergide—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000158	0.000861	CbGpPWpGaD
Methysergide—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000158	0.00086	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000157	0.000857	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000157	0.000856	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000157	0.000855	CbGpPWpGaD
Methysergide—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000157	0.000855	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000155	0.000844	CbGpPWpGaD
Methysergide—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000154	0.000837	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000153	0.000832	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000152	0.000825	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000151	0.000821	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000147	0.0008	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000145	0.000786	CbGpPWpGaD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000145	0.000786	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000143	0.000778	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000142	0.000775	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000141	0.000766	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00014	0.000762	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000139	0.000755	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000137	0.000746	CbGpPWpGaD
Methysergide—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000137	0.000744	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000137	0.000744	CbGpPWpGaD
Methysergide—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000136	0.00074	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000136	0.00074	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000129	0.000703	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000127	0.000693	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000127	0.00069	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000122	0.000662	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000121	0.000656	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00012	0.000655	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00012	0.000651	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000118	0.000643	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000117	0.000637	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000117	0.000637	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000117	0.000634	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00011	0.000599	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00011	0.000599	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000108	0.000585	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000107	0.000584	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000107	0.000581	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000106	0.000575	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000105	0.000569	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000104	0.000568	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000104	0.000567	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000104	0.000564	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000101	0.000552	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	9.97e-05	0.000543	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.82e-05	0.000534	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.77e-05	0.000531	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.76e-05	0.000531	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.73e-05	0.000529	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.72e-05	0.000529	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.69e-05	0.000527	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.65e-05	0.000525	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	9.6e-05	0.000522	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.53e-05	0.000518	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.49e-05	0.000516	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.48e-05	0.000516	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.47e-05	0.000515	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.45e-05	0.000514	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.41e-05	0.000512	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.21e-05	0.000501	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	9.06e-05	0.000493	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	8.95e-05	0.000487	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.92e-05	0.000485	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.92e-05	0.000485	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.88e-05	0.000483	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.88e-05	0.000483	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.83e-05	0.000481	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.82e-05	0.00048	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.77e-05	0.000477	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	8.69e-05	0.000473	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.66e-05	0.000471	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.58e-05	0.000467	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	8.45e-05	0.000459	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	8.2e-05	0.000446	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	8.1e-05	0.000441	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.06e-05	0.000439	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.96e-05	0.000433	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.92e-05	0.000431	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.73e-05	0.00042	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.69e-05	0.000418	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	7.64e-05	0.000416	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.23e-05	0.000393	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.2e-05	0.000392	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.19e-05	0.000391	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.16e-05	0.00039	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.02e-05	0.000382	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.98e-05	0.00038	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.88e-05	0.000374	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.81e-05	0.000371	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.81e-05	0.00037	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.76e-05	0.000368	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.68e-05	0.000363	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.62e-05	0.00036	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.54e-05	0.000356	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.51e-05	0.000354	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.25e-05	0.00034	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.22e-05	0.000338	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.22e-05	0.000338	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.19e-05	0.000337	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.18e-05	0.000336	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.14e-05	0.000334	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.06e-05	0.00033	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.01e-05	0.000327	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.77e-05	0.000314	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.76e-05	0.000314	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.73e-05	0.000311	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	5.67e-05	0.000309	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.65e-05	0.000307	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.65e-05	0.000307	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.61e-05	0.000305	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.6e-05	0.000305	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.6e-05	0.000304	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.56e-05	0.000302	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.44e-05	0.000296	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	5.35e-05	0.000291	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.27e-05	0.000287	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.22e-05	0.000284	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.21e-05	0.000284	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.18e-05	0.000282	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.11e-05	0.000278	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.07e-05	0.000276	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.04e-05	0.000274	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.02e-05	0.000273	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.76e-05	0.000259	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.58e-05	0.000249	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.56e-05	0.000248	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.27e-05	0.000232	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.25e-05	0.000231	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.15e-05	0.000226	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.13e-05	0.000224	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.86e-05	0.00021	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.84e-05	0.000209	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.69e-05	0.000201	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.65e-05	0.000199	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.65e-05	0.000199	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.63e-05	0.000197	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.58e-05	0.000195	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.55e-05	0.000193	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.34e-05	0.000182	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.34e-05	0.000181	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.71e-05	0.000147	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.69e-05	0.000146	CbGpPWpGaD
